Year archive

Moberg Pharma — 2014 filings

All 48 regulatory filings released by Moberg Pharma (MOB) in 2014, sourced directly from the official regulator.

48 Filings

2014 Period

2014 filings (48)

Filing	Released	Lang
Moberg Pharma launches new Kerasal Nail® line extension in beauty section of CVS, second largest U.S. drug chain Regulatory Filings	2014-12-05	English
Moberg Pharma lanserar ny produktvariant av Kerasal Nail på CVS, USAs näst största apotekskedja. Regulatory Filings	2014-12-05	Swedish
Moberg Pharma utser ny USA chef Board/Management Information	2014-11-20	Swedish
Moberg Pharma appoints new General Manager of U.S. business Board/Management Information	2014-11-20	English
Moberg Pharma changes in Board of Directors Board/Management Information	2014-11-17	English
Moberg Pharma genomför styrelseförändring Board/Management Information	2014-11-17	Swedish
Earnings Release 2014 Earnings Release Q3 2014	2014-11-14	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q3 2014	2014-11-14	English
MOBERG PHARMAS VALBEREDNING UTSEDD AGM Information	2014-11-11	Swedish
MOBERG PHARMA’S NOMINATION COMMITTEE APPOINTED AGM Information	2014-11-11	English
Moberg Pharma increases efficiency and reduces costs through expanded partnership with Emerson Group M&A Activity	2014-11-04	English
Moberg Pharma ökar effektivitet och minskar kostnader genom fördjupat samarbete med Emerson Group i USA Regulatory Filings	2014-11-04	Swedish
Första patienten inkluderad i fas ll studie med BUPI, en innovativ topikal formulering för behandling av smärta i munhålan Regulatory Filings	2014-10-28	Swedish
First patient included in phase ll study of BUPI, a novel topical formulation for treatment of oral pain Regulatory Filings	2014-10-28	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-09-25	English
Moberg Pharma meddelar positiva resultat från fas ll studie med MOB-015 för behandling av nagelsvamp Earnings Release FY 2014	2014-09-17	Swedish
Moberg Pharma announces successful results for MOB-015 in a Phase II study for the treatment of onychomycosis Regulatory Filings	2014-09-17	English
Moberg Pharma’s USA chef kommer att lämna i januari 2015 Board/Management Information	2014-08-28	Swedish
Moberg Pharma’s head of U.S. operations to resign by end of January 2015 Board/Management Information	2014-08-28	English
Declaration of Voting Results & Voting Rights Announcements 2014 Declaration of Voting Results & Voting Rights Announcements	2014-08-15	English
Earnings Release 2014 Earnings Release Q2 2014	2014-08-13	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q2 2014	2014-08-13	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-06-30	English
Change of number of shares and votes in Moberg Pharma Declaration of Voting Results & Voting Rights Announcements	2014-06-30	English
Förändring av antalet aktier och röster i Moberg Pharma Share Issue/Capital Change	2014-06-30	Swedish
Major Shareholding Notification 2014 Major Shareholding Notification	2014-06-19	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-06-18	English
Moberg Pharma announces prospectus regarding admission to trading of new shares Share Issue/Capital Change	2014-06-18	English
Moberg Pharma offentliggör prospekt avseende upptagande till handel av nya aktier Report Publication Announcement	2014-06-18	Swedish
Major Shareholding Notification 2014 Major Shareholding Notification	2014-05-30	English
Moberg Pharma genomför riktad nyemission om 60 MSEK för fortsatt expansion Share Issue/Capital Change	2014-05-28	Swedish
Moberg Pharma completes a directed share issue of SEK 60 million for continued expansion Share Issue/Capital Change	2014-05-28	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-05-22	English
Kommuniké från Moberg Pharmas årsstämma 2014 AGM Information	2014-05-13	Swedish
Bulletin from Moberg Pharma’s annual general meeting 2014 AGM Information	2014-05-13	English
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-13	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-13	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-05-06	English
Moberg Pharma acquires global rights to novel topical formulation for treatment of oral pain Capital/Financing Update	2014-04-14	English
Moberg Pharma förvärvar globala rättigheter till en innovativ topikal formulering för behandling av smärta i munhålan Capital/Financing Update	2014-04-14	Swedish
Annual Report 2013 Annual Report FY 2013	2014-04-11	Swedish
Annual Report 2013 Annual Report FY 2013	2014-04-11	English
Moberg Pharma launches new patent pending formulation of Kerasal Nail in the U.S. Regulatory Filings	2014-03-24	English
Moberg Pharma lanserar ny patentsökt formulering av Kerasal Nail i USA. Regulatory Filings	2014-03-24	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report Q4 2013	2014-02-20	Swedish
Audit Report / Information 2013 Audit Report / Information FY 2013	2014-02-20	English
Moberg Pharma and Menarini extend distribution agreement for Kerasal Nail to South East Asia Regulatory Filings	2014-02-14	English
Moberg Pharma och Menarini expanderar samarbete för Kerasal Nail till Sydostasien Regulatory Filings	2014-02-14	Swedish

Filings by year

2026 11 filings
2025 36 filings
2024 62 filings
2023 56 filings
2022 40 filings
2021 39 filings
2020 62 filings
2019 83 filings
2018 53 filings
2017 44 filings
2016 70 filings
2015 55 filings
2014 48 filings
2013 51 filings
2012 56 filings
2011 16 filings